Literature DB >> 34476740

Indole glucosinolates exhibit anti-inflammatory effects on Ehrlich ascites carcinoma cells through modulation of inflammatory markers and miRNAs.

Ayah Z Salem1, Dalia Medhat2, Shadia A Fathy1, Mohamed R Mohamed1, Zakaria El-Khayat2, Sherien M El-Daly3,4.   

Abstract

BACKGROUND: Nuclear factor-κB (NF-κB) has been identified as the major link between inflammation and cancer. Natural agents that inhibit this pathway are essential in attenuating inflammation induced by cancer or chemotherapeutic drugs. High intake of Brassicaceae vegetables has been determined to modulate essential pathways related to chronic diseases. In this study, we investigated the anti-proliferative and anti-inflammatory effects of the indole glucosinolates; indole-3-carbinol (I3C) and its metabolite 3,3-diindolylmethane (DIM) on the inflammatory biomarkers and miRNAs controlling the NF-κB pathway. METHODS AND
RESULTS: In our study, we inoculated Ehrlich ascites carcinoma (EAC) cells in female albino mice, which increased their packed cell volume and induced a significant increase in the levels of several cytokines and inflammatory biomarkers (NF-κB IL-6, IL-1b, TNF-α, and NO). A significant elevation in inflammatory-medicated miRNAs (miR-31 and miR-21) was also noted. Treatment with 5-fluorouracil (5-FU) significantly reduced packed cell volume and viable cell count. However, it was accompanied by a significant increase in the levels of inflammatory markers and expression of miR-31 and miR-21. Nevertheless, although treatment with indoles (I3C and DIM) significantly reduced the packed cell volume and viable cell count, their prominent effect was the marked reduction of all inflammatory biomarkers compared to both the EAC untreated group and the EAC group treated with 5-FU. Moreover, the anti-inflammatory effect of I3C or DIM was accompanied by a significant decrease in the expression of miR-31 and miR-21.
CONCLUSION: Our findings have; therefore, revealed that I3C and DIM have strong anti-inflammatory effects, implying that their use as a co-treatment with chemotherapeutic drugs can effectively improve the anti-tumor effect of chemotherapeutic drugs.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  3,3-Diindolylmethane; 5-Fluorouracil; Ehrlich ascites carcinoma; Indole-3-carbinol; Inflammation; Nuclear factor-κB; miR-21; miR-31

Mesh:

Substances:

Year:  2021        PMID: 34476740     DOI: 10.1007/s11033-021-06683-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  29 in total

1.  Modulatory Effect of Indoles on the Expression of miRNAs Regulating G1/S Cell Cycle Phase in Breast Cancer Cells.

Authors:  Sherien M El-Daly; Amira M Gamal-Eldeen; Shaimaa A Gouhar; Mahmoud T Abo-Elfadl; Gamila El-Saeed
Journal:  Appl Biochem Biotechnol       Date:  2020-07-25       Impact factor: 2.926

Review 2.  NF-κB and the link between inflammation and cancer.

Authors:  Joseph A DiDonato; Frank Mercurio; Michael Karin
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

3.  Abrin and ricin: new anti-tumour substances.

Authors:  J Y Lin; K Y Tserng; C C Chen; L T Lin; T C Tung
Journal:  Nature       Date:  1970-07-18       Impact factor: 49.962

4.  Comparison of the growth of the Ehrlich ascites tumor in male and female mice.

Authors:  P C Vincent; A Nicholls
Journal:  Cancer Res       Date:  1967-06       Impact factor: 12.701

5.  Effect of Au-dextran NPs as anti-tumor agent against EAC and solid tumor in mice by biochemical evaluations and histopathological investigations.

Authors:  Dalia Medhat; Jihan Hussein; Mehrez E El-Naggar; Mohamed F Attia; Mona Anwar; Yasmine Abdel Latif; Hoda F Booles; Safaa Morsy; Abdel Razik Farrag; Wagdy K B Khalil; Zakaria El-Khayat
Journal:  Biomed Pharmacother       Date:  2017-05-15       Impact factor: 6.529

6.  Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol.

Authors:  C J Grubbs; V E Steele; T Casebolt; M M Juliana; I Eto; L M Whitaker; K H Dragnev; G J Kelloff; R L Lubet
Journal:  Anticancer Res       Date:  1995 May-Jun       Impact factor: 2.480

7.  5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells.

Authors:  M Yasuda; S Kato; N Yamanaka; M Iimori; K Matsumoto; D Utsumi; Y Kitahara; K Amagase; S Horie; K Takeuchi
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity.

Authors:  Anwar Rayan; Jamal Raiyn; Mizied Falah
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

10.  Gene expression profiles alteration after infection of virus, bacteria, and parasite in the Olive flounder (Paralichthys olivaceus).

Authors:  Gyu-Hwi Nam; Anshuman Mishra; Jeong-An Gim; Hee-Eun Lee; Ara Jo; Dahye Yoon; Ahran Kim; Woo-Jin Kim; Kung Ahn; Do-Hyung Kim; Suhkmann Kim; Hee-Jae Cha; Yung Hyun Choi; Chan-Il Park; Heui-Soo Kim
Journal:  Sci Rep       Date:  2018-12-24       Impact factor: 4.379

View more
  2 in total

1.  Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy.

Authors:  Sajad Fakhri; Seyed Zachariah Moradi; Akram Yarmohammadi; Fatemeh Narimani; Carly E Wallace; Anupam Bishayee
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

2.  Multi-Functional Development and Utilization of Rapeseed: Comprehensive Analysis of the Nutritional Value of Rapeseed Sprouts.

Authors:  Zelin Xiao; Yuying Pan; Chao Wang; Xiongcai Li; Yiqing Lu; Ze Tian; Lieqiong Kuang; Xinfa Wang; Xiaoling Dun; Hanzhong Wang
Journal:  Foods       Date:  2022-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.